MCL1 and Bone marrow hypocellularity: Until recently a truly selective and potent small molecule inhibitor of MCL‐1 had yet to be developed, and a worrying caveat is that genetic deletion of MCL‐1 in mouse models resulted in bone marrow failure and myocardial toxicity [8].